Ferrari, Vittorio Domenico
 Distribuzione geografica
Continente #
NA - Nord America 1.267
EU - Europa 541
AS - Asia 344
OC - Oceania 4
AF - Africa 1
Totale 2.157
Nazione #
US - Stati Uniti d'America 1.261
CN - Cina 148
DE - Germania 109
UA - Ucraina 104
PL - Polonia 102
SG - Singapore 81
IT - Italia 72
HK - Hong Kong 54
FI - Finlandia 39
GB - Regno Unito 31
TR - Turchia 26
IE - Irlanda 24
RU - Federazione Russa 17
IN - India 14
SE - Svezia 13
FR - Francia 12
BE - Belgio 8
VN - Vietnam 8
CZ - Repubblica Ceca 6
AU - Australia 4
CA - Canada 4
ID - Indonesia 4
TW - Taiwan 4
IR - Iran 3
NL - Olanda 2
CR - Costa Rica 1
ES - Italia 1
KW - Kuwait 1
LV - Lettonia 1
MU - Mauritius 1
PA - Panama 1
TH - Thailandia 1
Totale 2.157
Città #
Fairfield 192
Woodbridge 121
Ashburn 120
Warsaw 102
Houston 93
Jacksonville 83
Cambridge 78
Singapore 70
Ann Arbor 69
Seattle 69
Wilmington 62
Chandler 54
Hong Kong 54
Dearborn 45
Princeton 44
Helsinki 31
New York 29
Beijing 24
Dublin 24
Istanbul 24
Nanjing 22
Boardman 13
Shanghai 13
Nanchang 10
Brescia 8
Changsha 8
Dong Ket 8
Lancaster 8
Munich 8
Brussels 7
Des Moines 7
San Diego 7
Washington 7
Brno 6
Hebei 6
Leawood 6
Milan 6
Guangzhou 5
Haikou 5
Jinan 5
Kunming 5
Salò 5
Shenyang 5
Turin 5
Hangzhou 4
Jakarta 4
Los Angeles 4
Nürnberg 4
Rovato 4
San Francisco 4
San Mateo 4
Tianjin 4
West Jordan 4
Ardabil 3
Chiswick 3
Dalmine 3
Hefei 3
Santa Clara 3
Taizhou 3
Verona 3
Vignate 3
Augusta 2
Canberra 2
Chicago 2
Ferrara 2
Gardone Val Trompia 2
Jiaxing 2
Kilburn 2
London 2
Melbourne 2
New Bedfont 2
Orange 2
Phoenix 2
Pune 2
Redwood City 2
Taichung 2
Toronto 2
Arcore 1
Asti 1
Bangkok 1
Borås 1
Cabrils 1
Cazzago San Martino 1
Clearwater 1
Cleveland 1
Erbusco 1
Fuzhou 1
Grozny 1
Hounslow 1
Karlsruhe 1
Kuwait City 1
Lanzhou 1
Livorno 1
Milzano 1
Naples 1
North York 1
Norwalk 1
Québec 1
Riga 1
Rome 1
Totale 1.688
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 191
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review 176
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 152
Primary Ewing's sarcoma of the sinonasal tract in adults: A challenging disease 147
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 131
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 115
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 109
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 108
Gonadal function in male patients with metastatic renal cell cancer treated with sunitinib: Effects of testosterone replacement on quality of life. 106
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 101
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial 98
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 96
Singular coexistence of anti-Hu syndrome, finger clubbing and pseudoscleroderma in small cell lung cancer. 94
Excavated Lung Metastases In Metastatic Rcc (mrcc): Pseudoprogression As A Response To Sunitinib 70
Efficacy of topic steroids in the management of asthma and chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients during treatment with nivolumab 62
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 60
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 55
null 50
Trapianto di midollo osseo nei linfomi linfoblastici e nel linfoma di Hodgkin dopo FTBI ed HD-ARAC 48
Should everolimus be stopped after radiological progression in metastatic insulinoma? A “cons” point of view 48
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 47
Trapianto di midollo osseo nelle leucemie acute mieloidi in RC. 39
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 38
Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome 32
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 28
Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma 7
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 4
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial 3
Totale 2.215
Categoria #
all - tutte 11.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.310


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020361 0 0 0 0 31 71 60 52 38 61 21 27
2020/2021500 18 61 41 72 38 41 11 52 37 51 46 32
2021/2022197 17 24 4 6 1 20 4 14 14 29 16 48
2022/2023165 27 7 10 7 12 42 0 11 29 1 3 16
2023/2024295 13 8 33 15 18 52 6 22 63 9 7 49
2024/2025181 9 14 6 92 60 0 0 0 0 0 0 0
Totale 2.215